← All companies

Uncommon Therapeutics

Active

A Disease Focused Biotech, Building Multiple Billion Dollar Drugs

W25·Winter 2025·Healthcare·San Francisco, CA, USA·Team of 2·Founded 2024

About

Our founder Noah, an experienced tech entrepreneur, was directly impacted by a severe genetic disease when his daughter was diagnosed with Rett Syndrome, a disease that afflicts 1 in 10,000 girls. Using an innovative polytherapy strategy, we’ve successfully improved her quality of life, and have designed new therapeutics that each could be worth billions and together could deliver a cure.

Founders

  • Noah Auerhahn· Founder

    Serial Entrepreneur Building Therapies and New Biz Models for Rare Disease

  • Ryan Lim· Founder

    Biotech entrepreneur and biomedical scientist specializing in modeling neurological disorders using stem cells, in vivo models, and computational biology to drive breakthroughs in neurological diseases

Product launches · 1 launch

Change history · none recorded

No changes recorded yet. Subsequent syncs will populate this timeline as fields drift.